Naief Abudaff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Naief Abudaff has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Andrew Guide
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication- Ankur D. Shah
Warren Alpert Medical School of Brown University, Providence, Rhode Island
1 shared publication Juan Pablo Arroyo
Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication- Nicole Wyatt
Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
1 shared publication - Osama El Shamy
Renal, Electrolyte, and Hypertension Division, Hospital of the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
1 shared publication - Robert A. Greevy
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication
Latest Publications
- Open Access
- 8 July 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (11) , 1683-1691
Ultrafiltration Patterns during Automated Peritoneal Dialysis: Findings and Insights to Peritoneal Physiology
Key Points: There is a consistent increase in ultrafiltration volumes achieved per cycle over the course of an automated peritoneal dialysis treatment session. A better understanding of intercycle ultrafiltration trends may inform prescription interventions that can improve patient retention. Surface area recruitment, mesenteric elasticity, and cumulative glucose concentration in the interstitium are possible explanations for our findings. Background: With the growing use of automated peritoneal dialysis (APD), it is important to improve our knowledge of the clinical patterns and physiology of APD treatment sessions. The ultrafiltration (UF) achieved during each cycle of an APD treatment is assumed to be relatively linear if the delivered prescription is the same. We set out to determine whether that is indeed the case. Methods: This is a single-center, cross-sectional study of patients on prevalent peritoneal dialysis (PD). All adult patients on APD (older than 18 years) who had been on PD for ≥3 months and ≥3 months on APD were included. Patients on continuous ambulatory PD or those with peritonitis within 3 months of the consent date were excluded. Individual treatment data from seven consecutive APD treatment sessions with consistent dialysate composition for each cycler exchange were collected for each patient. Results: Thirty-nine patients met the inclusion criteria and were enrolled. The probability of yielding a positive UF was 48.9% for cycle 1, rising to 90.5% by cycle 6. Adjusting for average dextrose concentration, dwell time, fill volume, solute transfer rate, and number of cycles, we observed that cycles 2–6 achieved progressively higher UF volumes than cycle 1 (P < 0.001). The first and last cycles demonstrated significantly different cycle UF volumes compared with a middle cycle (−230 and 277 ml, respectively, P < 0.001). Conclusions: We observed a consistent increase in UF volumes achieved per cycle over the course of an APD treatment session with numerous clinical and physiologic implications. This provides the foundation for future studies investigating peritoneal intercycle variations and membrane physiology.
- 8 July 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (11) , 1683-1691
Open AccessUltrafiltration Patterns during Automated Peritoneal Dialysis: Findings and Insights to Peritoneal Physiology
Key Points: There is a consistent increase in ultrafiltration volumes achieved per cycle over the course of an automated peritoneal dialysis treatment session. A better understanding of intercycle ultrafiltration trends may inform prescription interventions that can improve patient retention. Surface area recruitment, mesenteric elasticity, and cumulative glucose concentration in the interstitium are possible explanations for our findings. Background: With the growing use of automated peritoneal dialysis (APD), it is important to improve our knowledge of the clinical patterns and physiology of APD treatment sessions. The ultrafiltration (UF) achieved during each cycle of an APD treatment is assumed to be relatively linear if the delivered prescription is the same. We set out to determine whether that is indeed the case. Methods: This is a single-center, cross-sectional study of patients on prevalent peritoneal dialysis (PD). All adult patients on APD (older than 18 years) who had been on PD for ≥3 months and ≥3 months on APD were included. Patients on continuous ambulatory PD or those with peritonitis within 3 months of the consent date were excluded. Individual treatment data from seven consecutive APD treatment sessions with consistent dialysate composition for each cycler exchange were collected for each patient. Results: Thirty-nine patients met the inclusion criteria and were enrolled. The probability of yielding a positive UF was 48.9% for cycle 1, rising to 90.5% by cycle 6. Adjusting for average dextrose concentration, dwell time, fill volume, solute transfer rate, and number of cycles, we observed that cycles 2–6 achieved progressively higher UF volumes than cycle 1 (P < 0.001). The first and last cycles demonstrated significantly different cycle UF volumes compared with a middle cycle (−230 and 277 ml, respectively, P < 0.001). Conclusions: We observed a consistent increase in UF volumes achieved per cycle over the course of an APD treatment session with numerous clinical and physiologic implications. This provides the foundation for future studies investigating peritoneal intercycle variations and membrane physiology.